You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non erosive reflux disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Esophageal Reflux Disease Trial in Iksan

Recruiting
  • Non-erosive Reflux Disease
  • +2 more
  • DWP14012 20mg
  • +2 more
  • Iksan, Jeollabuk-do, Korea, Republic of
    Wonkwang University Hospital
Nov 6, 2023

Non-erosive Reflux Disease, Gastroesophageal Reflux Trial in New Orleans (Proton Pump Inhibitor (PPI) Therapy, Sucralfate)

Terminated
  • Non-erosive Reflux Disease
  • Gastroesophageal Reflux
  • New Orleans, Louisiana
  • +1 more
Jan 25, 2022

Gastroesophageal Reflux Disease, GERD, Gastroesophageal Erosion Trial in Moscow (diet adherence, No diet adherence, Change in

Recruiting
  • Gastroesophageal Reflux Disease
  • +5 more
  • diet adherence
  • +5 more
  • Moscow, Russian Federation
    Federal State Budgetary Scientific Institution "Federal Research
Aug 1, 2022

Non-erosive Reflux Disease, Diarrhea-Predominant Irritable Bowel Syndrome Trial in Beijing (WPQW granule, WPQW granule simulant)

Recruiting
  • Non-erosive Reflux Disease
  • Diarrhea-Predominant Irritable Bowel Syndrome
  • WPQW granule
  • WPQW granule simulant
  • Beijing, Beijing, China
    Xiyuan Hospital of China Academy of Chinese Medical Sciences
May 10, 2022

Non-erosive Reflux Disease, Erosive Esophagitis Trial in United States (BLI5100)

Enrolling by invitation
  • Non-erosive Reflux Disease
  • Erosive Esophagitis
  • Huntsville, Alabama
  • +20 more
May 25, 2023

Gastroesophageal; Reflux With Esophagitis, Gastroesophageal Reflux, GERD Trial in Moscow (Dietary assessment)

Recruiting
  • Gastroesophageal; Reflux With Esophagitis
  • +5 more
  • Dietary assessment
  • Moscow, Russian Federation
    Gastroenterology and Hepatology, FRC Nutrition and Biotechnology
Feb 2, 2022

Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet

Recruiting
  • Gastroesophageal Reflux Disease
  • Fexuprazan Hydrochloride
  • Busan, Korea, Republic of
    Co&Ping Otolaryngology Clinic
May 24, 2023

Non-erosive Reflux Disease Trial in United States (BLI5100, Placebo)

Recruiting
  • Non-erosive Reflux Disease
  • Huntsville, Alabama
  • +71 more
Jan 23, 2023

Non-erosive Reflux Disease Trial in Seoul (YYD601 20mg, Nexium 20mg, Placebos)

Completed
  • Non-erosive Reflux Disease
  • YYD601 20mg
  • +2 more
  • Seoul, Korea, Republic of
    Korea University Ansan Hospital
May 7, 2021

GERD, Non-erosive Reflux Disease, Functional Esophageal Disorders Trial (Upper endoscopy, esophageal manometry, 24-hour pH

Unknown status
  • GERD
  • +3 more
  • Upper endoscopy, esophageal manometry, 24-hour pH monitoring
  • (no location specified)
Feb 13, 2021

Non-Erosive Gastro-Esophageal Reflux Disease, Heartburn Trial in United States (Vonoprazan, Placebo)

Completed
Has Results
  • Non-Erosive Gastro-Esophageal Reflux Disease
  • Heartburn
  • Anniston, Alabama
  • +62 more
Dec 8, 2022

Non-erosive Reflux Disease Trial in Korea, Republic of (Ilaprazole)

Completed
  • Non-erosive Reflux Disease
  • Seongnam-si, Bundang-gu, Korea, Republic of
  • +10 more
Dec 30, 2020

A Multi-Center, Prospective, Observational Study to Evaluate

Recruiting
  • Gastroesophageal Reflux Disease
  • Fexuprazan Hydrochloride
  • Busan, Korea, Republic of
    Kosin University Gospel Hospital
Dec 13, 2022

Erosive Reflux Disease Trial in Iksan (Tegoprazan 50mg QD, Lansoprazole 30mg QD)

Completed
  • Erosive Reflux Disease
  • Tegoprazan 50mg QD
  • Lansoprazole 30mg QD
  • Iksan, Muwang-ro 895, Korea, Republic of
    Wonkwang University Hospital
Jul 28, 2022

GERD Trial in Seoul (JP-1366, JP-1366 , Esomeprazole 40mg)

Completed
  • GERD
  • Seoul, Korea, Republic of
    Severance Hospital and 19 hospitals
Jul 11, 2022

Erosive Esophagitis Trial in Seoul (YYD601 40mg, Nexium 40mg, Placebos)

Completed
  • Erosive Esophagitis
  • YYD601 40mg
  • +2 more
  • Seoul, Korea, Republic of
    Korea University Ansan Hospital
May 7, 2021

Non-erosive Reflux Disease Trial in Shanghai (LXI-15028, Placebo)

Completed
  • Non-erosive Reflux Disease
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Apr 7, 2020

Non-erosive Gastroesphageal Reflux Disease Trial in Seongnam (HIP1601, HGP1805)

Unknown status
  • Non-erosive Gastroesphageal Reflux Disease
  • Seongnam, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Apr 13, 2020

Non-Erosive Gastro-Esophageal Reflux Disease, Heartburn Trial in United States (Vonoprazan, Placebo)

Recruiting
  • Non-Erosive Gastro-Esophageal Reflux Disease
  • Heartburn
  • Athens, Alabama
  • +93 more
Aug 16, 2022

Improvement Effect on Subjective Symptom of FEXUCLUE Tab

Recruiting
  • Gastroesophageal Reflux Disease
  • Jeonju, Korea, Republic of
    Jeonbuk National University Hospital
Nov 14, 2022

Non-erosive Reflux Disease Trial in Beijing (Treatment group, Control group)

Unknown status
  • Non-erosive Reflux Disease
  • Treatment group
  • Control group
  • Beijing, Beijing, China
  • +1 more
Aug 20, 2019

GERD Trial in Prague (Radiofrequency Energy to the LES (Stretta Procedure), Stretta)

Recruiting
  • GERD
  • Radiofrequency Energy to the LES (Stretta Procedure)
  • Stretta
  • Prague, Czechia
    Military University Hospital Prague
Mar 11, 2023

Anxiety and Reflux Symptoms in Gastroesophageal Reflux Disease

Completed
  • GERD - Gastro-Esophageal Reflux Disease
  • Anxiety Disorders
  • High-Resolution Manometry, Upper-GI endoscopy, pH-Impedance testing
  • Cologne, NRW, Germany
    Department of General, Visceral, Tumor and Transplantation Surge
Nov 28, 2023

Non-erosive Gatroesophageal Reflux Disease Trial in Seoul (PPI)

Completed
  • Non-erosive Gatroesophageal Reflux Disease
  • Seoul, Korea, Republic of
    Yonsei university College of Medicine
Dec 27, 2019

Non-Erosive Gastroesophageal Reflux Disease Trial in Seoul (DWP14012 A mg, DWP14012 B mg, Placebo)

Unknown status
  • Non-Erosive Gastroesophageal Reflux Disease
  • DWP14012 A mg
  • +2 more
  • Seoul, Korea, Republic of
    Hanyang University Medical Center
Jun 23, 2019